For men who were on GnRH antagonists without a history of CVD indicator, there was an increased risk of developing arrhythmia (HR = 5.37; 95%; CI = 1.26‐22.87; I2 = 0%) compared to those on GnRH agonists. This evidence concerns the gene GNRH1 and Arrhythmia.